Session Name: 631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Precision targeting in MPN Session Date and Time: December 6, 2025; 9:30 AM – 11:00 AM ...
SUMMIT data for bezuclastinib in NonAdvSM selected for two oral presentations which will describe its best-in-class potentialNovel JAK2 V617F ...
This latest pattern emphasizes competency-based learning, focusing on conceptual understanding, analytical thinking, and ...
As Alphabet Inc.’s Google and other US tech behemoths pledge billions of dollars to build artificial intelligence ...
Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company’s registrational KYSA-6 Phase 3 MG trial. 100% of patie ...
The REZOLVE-AD Phase 2b study enrolled 393 patients with moderate-to-severe AD who had no prior treatment with biologic or ...
Hosted on MSN
CBSE reminds schools to submit registration data for class 9 and 11 students by October 16: Check details here
The Central Board of Secondary Education (CBSE) has issued a fourth reminder to all affiliated schools regarding the submission of registration data for Class IX and Class XI for the academic year ...
Some 22 million Americans are set to lose health insurance subsidies by the end of the year. Who are they, and what will happen if the subsidies are allowed to expire? These subsidies, known as ...
WASHINGTON — A judge has extended the deadline for AT&T customers to file a claim to be part of a $177 million settlement reached with the telecom giant over customer data breaches discovered in 2024.
30-day Data from the AMDS PERSEVERE Trial Demonstrates Visceral Malperfusion Resolution in 83%, and Renal Malperfusion Resolution in 74% of Affected Subjects Post-AMDS Implantation Real-World Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback